DOSSIER · 13F-HR · Q2 2026

SUPERSTRING CAPITAL MANAGEMENT LP

$158M in tracked AUM across 32 positions as of Q2 2026.

SC
CIK 0001931118 · last filed Jun 30, 2026
Total AUM
$158M
as of Q2 2026
Holdings
32
—
positions
Whale Score
62
62
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

SUPERSTRING CAPITAL MANAGEMENT LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
COGT
COGENT BIOSCIENCES INC
$13M343K8.4%
02
AXSM
AXSOME THERAPEUTICS INC.
$13M54K8.3%
03
GMAB
GENMAB A/S
$12M431K7.5%
04
CLDX
CELLDEX THERAPEUTICS INC NEW
$11M288K6.8%
05
TRVI
TREVI THERAPEUTICS INC
$10M524K6.2%
06
RVMD
REVOLUTION MEDICINES INC
$10M51K6.0%
07
DFTX
DEFINIUM THERAPEUTICS INC
$9M188K5.6%
08
VIR
VIR BIOTECHNOLOGY INC
$9M854K5.5%
09
IMVT
IMMUNOVANT INC
$8M208K5.1%
10
M96088105
UROGEN PHARMA LTD
$7M191K4.4%

Filing history

2026Q2Jun 30
$158M▲ 13.2%
32 positionsView →
2026Q1Mar 31
$140M▼ 25.1%
35 positionsView →
2025Q4Dec 31
$187M▲ 189.5%
45 positionsView →
2025Q3Sep 30
$65M▼ 23.6%
24 positionsLocked
2025Q2Jun 30
$84M▲ 0.5%
36 positionsLocked
2025Q1Mar 31
$84M▼ 27.2%
34 positionsLocked
2024Q4Dec 31
$115M▲ 1.1%
39 positionsLocked
2024Q3Sep 30
$114M▲ 44.0%
28 positionsLocked
2024Q2Jun 30
$79M▼ 47.5%
39 positionsLocked
2024Q1Mar 31
$151M▲ 7.9%
37 positionsLocked
2023Q4Dec 31
$140M—
30 positionsLocked